» Articles » PMID: 18023147

Prevalence of Self-reported Epilepsy in a Multiracial and Multiethnic Community in New York City

Overview
Journal Epilepsy Res
Specialty Neurology
Date 2007 Nov 21
PMID 18023147
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To estimate the prevalence of epilepsy in a racially and ethnically diverse neighborhood in New York City.

Methods: We used random-digit dialing to identify people with a history of epilepsy. We estimated the prevalence of active epilepsy and lifetime epilepsy.

Results: The age-adjusted prevalence of active epilepsy was 5.0 per 1000, and that of lifetime epilepsy was 5.9 per 1000. Prevalence appeared higher in Hispanics (active prevalence: 6.3 per 1000; lifetime prevalence: 7.5 per 1000) than in non-Hispanics (active prevalence: 4.1 per 1000; lifetime prevalence: 4.7 per 1000). Blacks appeared to have a lower prevalence of active epilepsy (5.2 per 1000) than whites (5.9 per 1000), but a higher lifetime prevalence (7.5 per 1000 vs. 5.9 per 1000). Ethnic and racial differences in access to epilepsy care were evident both in terms of drug treatment and use of emergency departments for care.

Conclusions: The prevalence of epilepsy in this predominantly minority urban community is similar to that reported in other contemporary studies. Less access to health care for black and Hispanic respondents, compared with white respondents, may have influenced self-reported active epilepsy prevalence estimates since the definition includes recent use of antiseizure medication.

Citing Articles

Disparities in Teleneurology Use in Medicaid Beneficiaries With Epilepsy by Practice Setting: Promoting Health Equity in Academic Centers.

Gotlieb E, Agarwal P, Blank L, Kwon C, Muxfeldt M, Young J Neurology. 2024; 102(9):e209348.

PMID: 38608210 PMC: 11175647. DOI: 10.1212/WNL.0000000000209348.


Disparities in adherence and emergency department utilization among people with epilepsy: A machine learning approach.

Bensken W, Vaca G, Williams S, Khan O, Jobst B, Stange K Seizure. 2023; 110:169-176.

PMID: 37393863 PMC: 10528555. DOI: 10.1016/j.seizure.2023.06.021.


A framework for health equity in people living with epilepsy.

Bensken W, Alberti P, Khan O, Williams S, Stange K, Vaca G Epilepsy Res. 2022; 188:107038.

PMID: 36332544 PMC: 9797034. DOI: 10.1016/j.eplepsyres.2022.107038.


Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update.

Asgharian P, Quispe C, Herrera-Bravo J, Sabernavaei M, Hosseini K, Forouhandeh H Front Pharmacol. 2022; 13:926607.

PMID: 36188551 PMC: 9521271. DOI: 10.3389/fphar.2022.926607.


The burden of epilepsy and unmet need in people with focal seizures.

Ioannou P, Foster D, Sander J, Dupont S, Gil-Nagel A, Drogon OFlaherty E Brain Behav. 2022; 12(9):e2589.

PMID: 36017757 PMC: 9480957. DOI: 10.1002/brb3.2589.